Substance use outcomes following treatment: Findings from the Australian Patient Pathways Study

Australian and New Zealand Journal of Psychiatry

Volumn 51, Issue 2, 2017, Pages 177-189

  Manning, Victoria ^a,b   Garfield, Joshua B B ^a,b   Best, David ^a,c   Berends, Lynda ^d   Room, Robin ^a,e,f   Mugavin, Janette ^a,e   Larner, Andrew ^a   Lam, Tina ^g   Buykx, Penny ^b,h   Allsop, Steve ^g   Lubman, Dan I ^a,b  

^a EASTERN HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^d AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^e LA TROBE UNIVERSITY   (Australia)

^f STOCKHOLM UNIVERSITY   (Sweden)

^g CURTIN UNIVERSITY   (Australia)

^h UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Alcohol; continuity of care; drug; mutual aid; substance dependence; treatment outcomes

Indexed keywords

ALCOHOL; AMPHETAMINE; CANNABIS; METHAMPHETAMINE; OPIATE;

ADULT; AGED; ALCOHOL ABSTINENCE; ALCOHOL ABUSE; AMPHETAMINE DEPENDENCE; ARTICLE; AUSTRALIA; AUSTRALIAN; CANNABIS ADDICTION; CONTROLLED STUDY; EDUCATIONAL STATUS; GENDER; HOMELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; OPIATE ADDICTION; PATIENT SATISFACTION; PROSPECTIVE STUDY; SINGLE (MARITAL STATUS); SOCIAL WELFARE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; UNEMPLOYMENT; ADOLESCENT; ALCOHOL-RELATED DISORDERS; CLINICAL TRIAL; FEMALE; MARIJUANA ABUSE; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; VICTORIA; WESTERN AUSTRALIA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALCOHOL-RELATED DISORDERS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; VICTORIA; WESTERN AUSTRALIA; YOUNG ADULT;

EID: 85012054617     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867415625815     Document Type: Article

References (44)

1. Australian Bureau of Statistics (ABS) (2007) National Survey of Mental Health and Wellbeing: Summary of Results. Canberra, ACT, Australia: ABS
2. Australian Crime Commission (ACC) (2015) The Australian Methylamphetamine Market: The National Picture. Canberra, ACT, Australia: ACC
3. Australian Institute of Health and Welfare (AIHW) (2014) Alcohol and Other Drug Treatment Services in Australia 2012-13. Canberra, ACT, Australia: AIHW
4. Babor TF, Stenius K, Romelsjö A, (2008) Alcohol and drug treatment systems in public health perspective: Mediators and moderators of population effects. International Journal of Methods in Psychiatric Research 17: S50-S59
5. Best D, (2014) Book Review-Risk and rehabilitation: Management and treatment of substance misuse and mental health problems in the criminal justice system, edited by Aaron Pycroft and Suzie Clift. Drugs: Education, Prevention & Policy 21: 179-180
6. Chi FW, Weisner CM, (2008) Nine-year psychiatric trajectories and substance use outcomes: An application of the group-based modeling approach. Evaluation Review 32: 39-58
7. Chi FW, Parthasarathy S, Mertens JR, et al. (2011) Continuing care and long-term substance use outcomes in managed care: Early evidence for a primary care-based model. Psychiatric Services 62: 1194-1200
8. Dawson DA, Grant BF, Stinson FS, et al. (2005) Recovery from DSM-IV alcohol dependence: United States, 2001-2002. Addiction 100: 281-292
9. Day E, Best D, Cantillano V, et al. (2008) Measuring the use and career histories of drug users in treatment: Reliability of the Lifetime Drug Use History (LDUH) and its data yield relative to clinical case notes. Drug and Alcohol Review 27: 171-177
10. Dennis M, Scott CK, (2007) Managing addiction as a chronic condition. Addiction Science & Clinical Practice 4: 45-55
11. Donmall M, Jones A, Davies L, et al. (2009) Summary of Key Findings from the Drug Treatment Outcomes Research Study (DTORS). London: Home Office
12. Donovan DM, Bigelow GE, Brigham GS, et al. (2012) Primary outcome indices in illicit drug dependence treatment research: Systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction 107: 694-708
13. Gossop M, Darke S, Griffiths P, et al. (1995) The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90: 607-614
14. Gossop M, Marsden J, Stewart D, et al. (2000) Reductions in acquisitive crime and drug use after treatment of addiction problems: 1-year follow-up outcomes. Drug and Alcohol Dependence 58: 165-172
15. Gossop M, Marsden J, Stewart D, et al. (2001) Outcomes after methadone maintenance and methadone reduction treatments: Two-year follow-up results from the National Treatment Outcome Research Study. Drug and Alcohol Dependence 62: 255-264
16. Jacobson NS, Truax P, (1991) Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 59: 12-19
17. Kaskutas LA, (2009) Alcoholics Anonymous effectiveness: Faith meets science. Journal of Addictive Diseases 28: 145-157
18. Kelly JF, Stout RL, Slaymaker V, (2013) Emerging adults' treatment outcomes in relation to 12-step mutual-help attendance and active involvement. Drug and Alcohol Dependence 129: 151-157
19. Lenaerts E, Mathei C, Matthys F, et al. (2014) Continuing care for patients with alcohol use disorders: A systematic review. Drug and Alcohol Dependence 135: 9-21
20. Lubman D, Manning V, Best D, et al. (2014) A Study of Patient Pathways in Alcohol and Other Drug Treatment. Fitzroy, VIC, Australia: Turning Point
21. McKay JR, Carise D, Dennis ML, et al. (2009) Extending the benefits of addiction treatment: Practical strategies for continuing care and recovery. Journal of Substance Abuse Treatment 36: 127-130
22. McKeganey N, Bloor M, McIntosh J, et al. (2008) Key Findings from the Drug Outcome Research in Scotland (DORIS) Study. Glasgow: Centre for Drug Misuse Research, University of Glasgow
23. McKetin R, Najman JM, Baker AL, et al. (2012) Evaluating the impact of community-based treatment options on methamphetamine use: Findings from the Methamphetamine Treatment Evaluation Study (MATES). Addiction 107: 1998-2008
24. McLellan AT, Lewis DC, O'Brien CP, et al. (2000) Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association 284: 1689-1695
25. Manning V, Best D, Faulkner N, et al. (2012) Does active referral by a doctor or 12-Step peer improve 12-step meeting attendance? Results from a pilot randomised control trial. Drug and Alcohol Dependence 126: 131-137
26. Napper LE, Fisher DG, Johnson ME, et al. (2010) The reliability and validity of drug users' self reports of amphetamine use among primarily heroin and cocaine users. Addictive Behaviors 35: 350-354
27. Nguyen TD, Attkisson CC, Stegner BL, (1983) Assessment of patient satisfaction: Development and refinement of a service evaluation questionnaire. Evaluation and Program Planning 6: 299-313
28. O'Brien CP, McLellan AT, (1996) Myths about the treatment of addiction. The Lancet 347: 237-240
29. Pettinati HM, Belden PP, Evans BD, et al. (1996) The natural history of outpatient alcohol and drug abuse treatment in a private healthcare setting. Alcoholism: Clinical and Experimental Research 20: 847-852
30. Popovici I, French MT, McKay JR, (2008) Economic evaluation of continuing care interventions in the treatment of substance abuse: Recommendations for future research. Evaluation Review 32: 547-568
31. Project MATCH Research Group (1997) Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol 58: 7-29
32. Ryan A, Holmes J, Hunt V, et al. (2014) Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings. Drug and Alcohol Review 33: 33-42
33. Simpson DD, (2004) A conceptual framework for drug treatment process and outcomes. Journal of Substance Abuse Treatment 27: 99-121
34. Simpson DD, Sells SB, (1990) Opioid Addiction and Treatment: A 12-Year Follow-Up. Malabar, FL: Krieger
35. Stavro K, Pelletier J, Potvin S, (2013) Widespread and sustained cognitive deficits in alcoholism: A meta-analysis. Addiction Biology 18: 203-213
36. Teesson M, Hall W, Slade T, et al. (2010) Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: Findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction 105: 2085-2094
37. Teesson M, Marel C, Darke S, et al. (2015) Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian Treatment Outcome Study. Addiction 110: 986-993
38. Teesson M, Mills K, Ross J, et al. (2008) The impact of treatment on 3 years' outcome for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Addiction 103: 80-88
39. Teesson M, Ross J, Darke S, et al. (2006) One year outcomes for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Dependence 83: 174-180
40. Timko C, Debenedetti A, Billow R, (2006) Intensive referral to 12-step self-help groups and 6-month substance use disorder outcomes. Addiction 101: 678-688
41. UKATT Research Team (2005) Effectiveness of treatment for alcohol problems: Findings of the randomised UK alcohol treatment trial (UKATT). British Medical Journal 331: 541
42. Vanderplasschen W, Vandevelde S, Broekaert E, (2014) Therapeutic Communities for Treating Addictions in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction
43. White WL, (2009) The mobilization of community resources to support long-term addiction recovery. Journal of Substance Abuse Treatment 36: 146-158
44. WHO ASSIST Working Group (2002) The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development, reliability and feasibility. Addiction 97: 1183-1194